moa of glp-1 agonists Discovery GLP-1–Based Drugs for the Treatment of Obesity Major physiological roles of GLP-1

Publications occasionally reference the potential for oral exploration

Eur J Immunol 53(7):2250232 Wang S et al (2025) Balancing microglial density and activation in central nervous system development and disease

10.1016/j.biopha.2021.111557 Biomed

The N-terminal half of these proteins comprises N-terminal band 4.1, ezrin, radixin, moesin (FERM) domain followed by Src homology 2 (SH2) domain, which were primarily defined as Janus homology (JH) domains 37 (60)

Inhibitors do not convert TGR into an NADPH oxidase Several covalent inhibitors of TGR are electrophilic compounds reacting with the Sec residue at the C-terminus, which induce a transition in the enzyme from an antioxidant to a pro-oxidant with increased NADPH consumption 20,45